# Comparing Doses of Intrathecal Dexmedetomidine

> **NCT07395271** · PHASE4 · COMPLETED · sponsor: **Bahria International Hospital** · enrollment: 60 (actual)

## Conditions studied

- Dexmedetomidine

## Interventions

- **DRUG:** Dexmedetomidine 5 mcg
- **DRUG:** Dexmedetomidine 10 mcg

## Key facts

- **NCT ID:** NCT07395271
- **Lead sponsor:** Bahria International Hospital
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-22
- **Primary completion:** 2026-01-21
- **Final completion:** 2026-01-21
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07395271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07395271, "Comparing Doses of Intrathecal Dexmedetomidine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07395271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*